Don't Suggest Xarelto for Most Coronary or Peripheral Artery Disease Patients

December 2018

You'll hear debate about adding Xarelto (rivaroxaban) to aspirin for stable coronary artery disease (CAD) or peripheral artery disease (PAD).

In fact, there's a new Xarelto 2.5 mg dose...to be given twice daily WITH aspirin 81 mg/day to reduce CV events in chronic CAD or PAD patients.

You may hear reps call this the "vascular" dose of Xarelto...versus the 10, 15, and 20 mg doses for venous thromboembolism or atrial fib.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Influenza Compare Xofluza to Tamiflu for Treating the Flu
Antithrombotics Don't Suggest Xarelto for Most Coronary or Peripheral Artery Disease Patients
Vaccines Consider Whether Gardasil 9 May Benefit Patients Over Age 26
Migraine Don't Jump to a CGRP Antagonist for Migraine Prophylaxis
Raynaud's Know Which Meds Worsen or Improve Raynaud's Phenomenon
Aspirin Don't Recommend Aspirin to Prevent Cancer
Supplements Be Ready for Questions About the Activated Charcoal "Health" Trend
Biosimilars Address Confusion About Biosimilars
Depression Weigh Antidepressant Options for Older Patients
Hyponatremia Stay Alert for Meds That May Lead to Low Sodium Levels
Pediatrics Prepare for Questions About Treating Croup
Med Safety Extinguish Issues With Meds That Can Catch Fire